Cofoe Medical TechnologyLtd Past Earnings Performance
Past criteria checks 4/6
Cofoe Medical TechnologyLtd has been growing earnings at an average annual rate of 15%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 17.9% per year. Cofoe Medical TechnologyLtd's return on equity is 7.7%, and it has net margins of 11.7%.
Key information
15.0%
Earnings growth rate
7.0%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 17.9% |
| Return on equity | 7.7% |
| Net Margin | 11.7% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cofoe Medical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 3,223 | 376 | 843 | 127 |
| 30 Jun 23 | 3,200 | 370 | 825 | 127 |
| 31 Mar 23 | 3,232 | 386 | 826 | 127 |
| 31 Dec 22 | 2,977 | 302 | 755 | 118 |
| 30 Sep 22 | 2,456 | 292 | 657 | 95 |
| 30 Jun 22 | 2,472 | 343 | 612 | 91 |
| 31 Mar 22 | 2,229 | 349 | 529 | 80 |
| 01 Jan 22 | 2,276 | 429 | 482 | 71 |
| 30 Sep 21 | 2,331 | 397 | 426 | 64 |
| 30 Jun 21 | 2,246 | 367 | 434 | 56 |
| 31 Mar 21 | 2,408 | 418 | 464 | 48 |
| 31 Dec 20 | 2,375 | 424 | 487 | 43 |
| 31 Dec 19 | 1,462 | 124 | 411 | 16 |
| 31 Dec 18 | 1,087 | 66 | 305 | 11 |
| 31 Dec 17 | 851 | -24 | 279 | 10 |
Quality Earnings: 301087 has high quality earnings.
Growing Profit Margin: 301087's current net profit margins (11.7%) are lower than last year (11.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301087's earnings have grown by 15% per year over the past 5 years.
Accelerating Growth: 301087's earnings growth over the past year (28.9%) exceeds its 5-year average (15% per year).
Earnings vs Industry: 301087 earnings growth over the past year (28.9%) exceeded the Medical Equipment industry -1.3%.
Return on Equity
High ROE: 301087's Return on Equity (7.7%) is considered low.